SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-540577
Filing Date
2016-04-14
Accepted
2016-04-14 06:14:06
Documents
7
Effectiveness Date
2016-04-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A d176927ddefa14a.htm DEFA14A 29889
2 GRAPHIC g176927g66h25.jpg GRAPHIC 2672
3 GRAPHIC g176927g72o76.jpg GRAPHIC 4027
4 GRAPHIC g176927gp_001.jpg GRAPHIC 19235
5 GRAPHIC g176927gp_002.jpg GRAPHIC 8879
6 GRAPHIC g176927gp_004.jpg GRAPHIC 5388
7 GRAPHIC g176927gp_005.jpg GRAPHIC 5991
  Complete submission text file 0001193125-16-540577.txt   95423
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 161570375
SIC: 2834 Pharmaceutical Preparations